Vancomycin resistance

Vancomycin resistance is defined as the nonsusceptibility of bacteria to the action of vancomycin, an inhibitor of cell wall synthesis. This resistance manifests when bacterial strains acquire the ability to withstand the bactericidal effects of vancomycin, rendering this last-resort antibiotic ineffective against infections caused by such organisms. The resistance mechanism fundamentally compromises one of the primary therapeutic options for treating serious Gram-positive infections when other antibiotics fail.

Source-backed clinical feature detail for vancomycin resistance is not yet available, as vancomycin resistance is a property of bacterial strains rather than a clinical syndrome itself. The clinical manifestations arise from the infections caused by resistant organisms, which may include complicated skin infections, bloodstream infections, endocarditis, bone and joint infections, and meningitis. The loss of vancomycin efficacy limits treatment options for these serious infections, potentially leading to poorer clinical outcomes when alternative therapies are less effective or unavailable.

Vancomycin resistance has emerged as a significant public health concern, particularly in healthcare settings where antibiotic selection pressure is highest. The increasing emergence of vancomycin-resistant enterococci has prompted the development of clinical guidelines restricting vancomycin use to specific indications. Resistance development is closely linked to antibiotic utilization patterns, with overuse and misuse of vancomycin contributing to selective pressure that favors resistant bacterial populations. The WHO has classified vancomycin as critically important for human medicine, reflecting its essential role in treating infections unresponsive to other antibiotics.

Vancomycin resistance is transmitted through the spread of resistant bacterial strains rather than direct transmission of resistance between bacteria. Resistant organisms can spread between patients in healthcare settings through direct contact, contaminated surfaces, or via healthcare worker hands. The resistance genes themselves may be transferred between bacterial species through horizontal gene transfer mechanisms. Infection control measures, including contact precautions and environmental cleaning, are critical for limiting the spread of vancomycin-resistant organisms.

Source-backed risk group detail specifically for vancomycin resistance acquisition is not yet available. However, patients at elevated risk for infections with vancomycin-resistant organisms typically include those with prolonged hospitalization, recent antibiotic exposure, invasive medical devices, immunocompromise, or residence in healthcare facilities with high rates of resistant organisms. The emergence of vancomycin-resistant enterococci has been particularly noted in intensive care unit settings and among patients with significant healthcare exposure.

Prevention of vancomycin resistance centers on antimicrobial stewardship programs that restrict vancomycin use to clinically appropriate indications. Current guidelines recommend reserving vancomycin for treatment of serious infections caused by methicillin-resistant staphylococci and other Gram-positive organisms when alternative agents are unsuitable. Rigorous infection control practices, including hand hygiene and environmental decontamination, help prevent transmission of resistant organisms. Surveillance for resistant strains enables early detection and implementation of containment measures.

Vancomycin resistance surveillance provides essential data for tracking antimicrobial resistance trends and informing public health interventions. Monitoring should capture both vancomycin-resistant enterococci and emerging vancomycin-intermediate or resistant Staphylococcus aureus strains. Laboratory-based surveillance with standardized susceptibility testing methodologies is critical for accurate resistance detection. Integration of resistance data with antibiotic consumption metrics enhances understanding of the relationship between antibiotic use and resistance emergence.

1. 1 Wikidata. vancomycin resistance.
2. 2 Wikipedia. Vancomycin - Wikipedia.

ICD-10

ICD-11

Total cases

766

Peak month

2023-03

Coverage

1 reporting countries · 2012-09-14 → 2026-05-02